Evidence map›Paper›PMID 31134649›Full record

ArticleAlimentary pharmacology & therapeutics2019

Editorial: combination immunosuppressive therapy to treat Crohn's disease - ready for all age groups? Authors' reply.

Siddharth Singh, Vipul Jairath, Stitt Lw, Zou G, Khanna R, Dulai Ps, Sandborn Wj, Feagan Bg

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Alimentary pharmacology & therapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Siddharth SinghDivision of Gastroenterology, University of California San Diego, La Jolla, California, Research Institute, London, Ontario, Canada.ORCID 0000-0002-2640-7269
Vipul JairathDepartment of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.ORCID 0000-0002-1092-0033
Stitt LwRobarts Research Institute, London, Ontario, Canada.
Zou GDepartment of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
Khanna RDepartment of Medicine, Division of Gastroenterology, University Hospital, Ontario, Canada.
Dulai PsDivision of Gastroenterology, University of California San Diego, La Jolla, California, Research Institute, London, Ontario, Canada.
Sandborn WjDivision of Gastroenterology, University of California San Diego, La Jolla, California, Research Institute, London, Ontario, Canada.
Feagan BgDepartment of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.

Funding

Comparative Risks and Benefits of Pharmacological Therapies for Older Patients with Inflammatory Bowel DiseasesK23DK117058 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SINGH, SIDDHARTH · 2018 to 2022
$971k
NIDDK NIH HHS K23 DK117058
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Crohn DiseaseAgedHumansImmunosuppression TherapyImmunosuppressive AgentsImmunosuppressive Agents

Identifiers

PMID31134649
PMCPMC6581562

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.